EGFR Clinical Trial Hi everyone, Is anyone doing specific EGFR clinical trials? TIA

EGFR Clinical Trials - What You Should Know

Great question! Yes, there are active EGFR-targeted clinical trials, and I can help you understand what's available and how to find them.

What EGFR Means (Quick Context)

EGFR (epidermal growth factor receptor) is a protein found on cancer cells that helps them grow. When your tumor has an EGFR mutation or overexpression, it means the cancer is "addicted" to this growth signal—which is actually good news because doctors can target it specifically with drugs.

Current EGFR Trial Landscape

According to resources from CancerPatientLab webinars on clinical trial matching, there are multiple ongoing EGFR-targeted trials, particularly for:

• EGFR exon 20 insertions (a specific type of EGFR mutation)
• Standard EGFR mutations (like exon 19 deletions and L858R mutations)
• Combination trials pairing EGFR inhibitors with other drugs

Real Example from the Field

According to Chris Beardmore's work on clinical trial access, researchers have successfully identified and enrolled patients with EGFR exon 20 insertion mutations in targeted trials. They've enrolled patients at multiple sites within just 2 months by using accelerated trial matching processes—showing that these trials ARE actively recruiting.

How to Find EGFR Trials Relevant to YOUR Case

Step 1: Get Your Genomic Testing

• You'll need NGS (next-generation sequencing) testing to identify your specific EGFR mutation type
• According to Selin Kurnaz from Massive Bio, NGS testing is crucial because "a huge portion of the clinical trial world is targeted therapy, precision medicine"
• Different EGFR mutations respond to different drugs, so knowing your specific mutation matters

Step 2: Use Trial Matching Services The webinars highlight several approaches:

• Massive Bio - Uses AI to match your specific mutation and treatment history to appropriate trials
• TrialMatch platforms - Screen trials based on your genomic profile and medical history
• NCI's trial database - National Cancer Institute maintains comprehensive trial listings

Step 3: Key Questions to Ask Your Oncologist

1. "Do I have NGS testing results that show my specific EGFR mutation type?" (This determines which trials you qualify for)
2. "Are there EGFR-targeted trials available for my specific mutation at nearby cancer centers?"
3. "What phase are these trials in, and what's the drug being tested?" (Phase 1 vs. Phase 2/3 have different risk/benefit profiles)
4. "Have I exhausted standard EGFR inhibitors, or would a trial be appropriate now?"
5. "What are the travel requirements and is travel covered?" (According to the webinars, some trials cover travel, others don't—depends on the sponsor)

Important Context About Trial Access

According to Sumit Subudhi's advice on trial strategy: Don't wait until you've exhausted all standard treatments before considering trials. Strategic trial placement between standard therapies can preserve your options and potentially access newer approaches earlier.

Major cancer centers with strong EGFR trial programs include:

• MD Anderson Cancer Center
• Memorial Sloan Kettering
• UCSF
• Johns Hopkins
• Duke University
• Fred Hutchinson Cancer Center

These institutions often have multiple EGFR trials running simultaneously.

Next Steps

1. Confirm your NGS results - Make sure you have documented EGFR mutation type
2. Contact a trial matching service - They can screen hundreds of trials against your specific profile
3. Consult at an academic cancer center - They'll have the most current trial information and can discuss strategic timing

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.